All Stories

  1. Adipose-derived mesenchymal stem cells improved acute renal failure induced by ischemia–reperfusion injury: Focusing on toll-like receptor 4 activity and endoplasmic reticulum stress response
  2. Palmatine enhances osteogenesis in hADMSCs via antioxidant enzyme upregulation and early RUNX2 activation
  3. Characterization of sensory nerve conduction abnormalities at the time of ALS diagnosis
  4. Hippocampal Vascularization Patterns and Its Role in Vascular Impairment
  5. Unveiling the Therapeutic Potential of Small Molecule of SVAK-12: A Comprehensive In Silico, In Vitro, and In Vivo Studies on its Neuroprotective Effects and Molecular Interactions in Parkinson's Disease
  6. Prenatal exposure to Bisphenol A sex-specifically disrupts prepulse inhibition and decreases parvalbumin-positive neurons in the prefrontal cortex of adult rats
  7. Comparative analysis of β-Estradiol and testosterone on lipid droplet accumulation, and regulatory protein expression in palmitate/oleate-induced fatty HepG2 cells
  8. Sodium Phenylbutyrate and Tauroursodeoxycholic Acid: A Story of Hope Turned to Disappointment in Amyotrophic Lateral Sclerosis Treatment
  9. Uncovering the six-month impact of COVID-19 on acute ischemic stroke patients: A hospital cohort study
  10. Parkinson’s Disease and Epilepsy: A bioinformatics analysis
  11. Masitinib: The promising actor in the next season of the Amyotrophic Lateral Sclerosis treatment series
  12. Strong Binding of Phytochemicals to the Catalytic Domain of Tyrosine Hydroxylase as a Trojan Horse Decreases Dopamine in Dopaminergic Cells: Pharmaceutical Considerations in Schizophrenia and Parkinson’s Disease
  13. Modulation of autophagy by melatonin via sirtuins in stroke: From mechanisms to therapies
  14. Heart Failure Status among Acute Ischemic Stroke Patients: A Hospital-Based Study
  15. Co-delivery of curcumin and Bcl-2 siRNA to enhance therapeutic effect against breast cancer cells using PEI-functionalized PLGA nanoparticles
  16. Experimental in Vitro and in Vivo Models of Demyelinating Disorders
  17. Fingolimod Nanoemulsions at Different Particle Sizes Define the Fate of Spinal Cord Injury Recovery
  18. Chitosan: A versatile bio-platform for breast cancer theranostics
  19. Particle Size of Drug Nanocarriers Defines the Fate of Spinal Cord Injury’s Recovery
  20. Mesenchymal Stem Cell Therapies for Paraplegia: Preclinical and Clinical Studies
  21. Differentiation of Mesenchymal Stem Cells Derived From Human Adipose Tissue Into Cholinergic-like Cells; in vitro
  22. New Horizons in Hydrogels for Methotrexate Delivery
  23. Melatonin Regulates Neuroinflammation Ischemic Stroke Damage through Interactions with Microglia in Reperfusion phase
  24. Reactive Astrocyte Gliosis: Production of Inhibitory Molecules
  25. Evaluation of the neuroprotective effects of electromagnetic fields and coenzyme Q 10 on hippocampal injury in mouse
  26. Small molecule of sphingosine as a rescue of dopaminergic cells: A cell therapy approach in neurodegenerative diseases therapeutics
  27. Intra-arterial Drug Delivery to the Ischemic Brain in Rat Middle Cerebral Artery Occlusion Model
  28. Human Endometrial Stem Cell Isolation from Endometrium and Menstrual Blood
  29. Poster Viewing Session IV
  30. Comparative capability of menstrual blood versus bone marrow derived stem cells in neural differentiation
  31. Differentiation potential of menstrual blood- versus bone marrow-stem cells into glial-like cells